Sungwon Lim News Today

A tech startup wants to use AI to help veterinarians give targeted drugs for a dog’s cancer treatment—but is it a helpful tool or are they barking up the wrong tree?

With its AI-powered technology, the company has developed a groundbreaking solution for identifying optimal drug treatments for individual dogs and cats with blood cancers.

MOUNTAIN VIEW, Calif., December 19, 2023--ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

ImpriMed, Inc., a Palo Alto, Calif.-based veterinary precision medicine startup, closed a total of $8m in Pre-Series A funding with $7.7m from VCs and the rest as government grant. The round was led by HG Initiative and other participants include Draper Associates, Draper Dragon, BonAngels, Murex Partners, Translink Investment, Primer Sazze, FuturePlay, and ES Investor. The company plans to use the new funding to develop additional prediction models for their current target patients in canine ...